CXCR4 and breast carcinoma: Potential therapeutic strategies have been developing by targeting CXCR4 or its ligand using antibodies, small peptides, or small interfering RNAs (siRNAs), and efficacy has been shown in inhibiting primary tumor growth and metastasis of breast cancer [22,23,24].